These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 35688777)
1. Baseline MD Anderson Symptom Inventory Score is Strongly Associated With Patient-reported Acute and Late Toxicity Following (Chemo) Radiotherapy for Head and Neck Cancers. Barker CL; Price GJ; Lee LW; McPartlin A Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):683-689. PubMed ID: 35688777 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers. Ren J; Pang W; Hueniken K; Haddad G; Hope A; Huang SH; Spreafico A; Hansen AR; Perez-Ordonez B; Goldstein DP; Bratman SV; Zhang W; Zhao Y; Xu W; de Almeida JR; Liu G Cancer; 2022 Feb; 128(3):497-508. PubMed ID: 34597435 [TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Sheu T; Fuller CD; Mendoza TR; Garden AS; Morrison WH; Beadle BM; Phan J; Frank SJ; Hanna EY; Lu C; Cleeland CS; Rosenthal DI; Gunn GB Otolaryngol Head Neck Surg; 2014 Oct; 151(4):619-26. PubMed ID: 25104816 [TBL] [Abstract][Full Text] [Related]
4. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Rosenthal DI; Mendoza TR; Chambers MS; Burkett VS; Garden AS; Hessell AC; Lewin JS; Ang KK; Kies MS; Gning I; Wang XS; Cleeland CS Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1355-61. PubMed ID: 18501527 [TBL] [Abstract][Full Text] [Related]
5. M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Viganò A; De Felice F; Iacovelli NA; Alterio D; Facchinetti N; Oneta O; Bacigalupo A; Tornari E; Ursino S; Paiar F; Caspiani O; Di Rito A; Musio D; Bossi P; Steca P; Jereczek-Fossa BA; Greco A; Orlandi E Oral Oncol; 2021 Apr; 115():105189. PubMed ID: 33549926 [TBL] [Abstract][Full Text] [Related]
6. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline? Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815 [TBL] [Abstract][Full Text] [Related]
7. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry. van Dijk LV; Mohamed ASR; Ferrarotto R; McCoy LA; Sharafi CS; Jones E; Steele K; Moreno AC; Lai SY; Garden AS; Myers JN; Rosenthal DI; Fuller CD; Hutcheson KA; Cancer; 2021 Jul; 127(14):2453-2464. PubMed ID: 33788956 [TBL] [Abstract][Full Text] [Related]
8. Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer Patients. Yarschenko AH; Yannitsos DH; Weppler S; Barbera L; Quon H; Sun Q; Smith W Laryngoscope; 2022 Dec; 132(12):2388-2395. PubMed ID: 35247215 [TBL] [Abstract][Full Text] [Related]
9. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. Dohopolski MJ; Diao K; Hutcheson KA; Akhave NS; Goepfert RP; He W; Lei XJ; Peterson SK; Shen Y; Sumer BD; Smith BD; Sher DJ JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):697-707. PubMed ID: 37382943 [TBL] [Abstract][Full Text] [Related]
10. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325 [TBL] [Abstract][Full Text] [Related]
11. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299 [TBL] [Abstract][Full Text] [Related]
12. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. ; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224 [TBL] [Abstract][Full Text] [Related]
13. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822 [TBL] [Abstract][Full Text] [Related]
14. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162 [TBL] [Abstract][Full Text] [Related]
15. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. ; Kamal M; Rosenthal DI; Volpe S; Goepfert RP; Garden AS; Hutcheson KA; Al Feghali KA; Meheissen MAM; Eraj SA; Dursteler AE; Williams B; Smith JB; Aymard JM; Berends J; White AL; Frank SJ; Morrison WH; Cardoso R; Chambers MS; Sturgis EM; Mendoza TR; Lu C; Mohamed ASR; Fuller CD; Gunn GB Radiother Oncol; 2018 Jan; 126(1):75-80. PubMed ID: 29229507 [TBL] [Abstract][Full Text] [Related]
16. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer. Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841 [TBL] [Abstract][Full Text] [Related]
17. Taste changes during radiotherapy for head and neck cancer. Mathlin J; Courtier N; Hopkinson J Radiography (Lond); 2023 Jul; 29(4):746-751. PubMed ID: 37224583 [TBL] [Abstract][Full Text] [Related]
18. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer. Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198 [TBL] [Abstract][Full Text] [Related]
19. Supportive care among head and neck cancer patients: An initial validation of the Dutch version of the Performance Status Scale for Head and Neck Cancer (D-PSS-HN). Baudelet M; Van den Steen L; Wouters S; De Bodt M; Vanderveken O; Duprez F; Van Nuffelen G Int J Lang Commun Disord; 2023; 58(5):1668-1679. PubMed ID: 37189297 [TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires. Steen-Olsen EB; Stormoen DR; Kristensen CA; Vogelius IR; Holländer-Mieritz C; Pappot H Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4199-4206. PubMed ID: 35357578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]